BETTER EVIDENCE TO BUILD CONFIDENCE
Abbott provides a robust body of clinical evidence encompassing clinical data and outcomes from tens of thousands of patients across our structural heart portfolio of products.*
*Data on file at Abbott
IN-DEPTH DATA ABOUT STRUCTURAL HEART PRODUCTS
With our Clinical Insights and Bulletins, you can take a deeper dive into clinical outcomes related to structural heart products. Designed for ease of viewing, these pieces give you a broader perspective about study outcomes along with product safety and performance.
TEER (Transcatheter Edge-to-Edge Repair)
TriClip™ for TEER
Read moreReducing heart failure hospitalization and empowering patients to live their best lives
TAVI (Transcatheter Aortic Valve Implantation)
Navitor™ TAVI System: Real-World Experience
Read more10.6% New PPI With Navitor™ Vision Valve After 20 Procedures
Navitor™ Vision Valve: PVL Sealing by Unique Design
Read more0% Moderate to Severe PVL With Navitor™ Active-Sealing Cuff
Navitor™ Valve: Small Aortic Annuli
Read moreSingle-Digit Mean Gradients With The Self-Expanding Navitor™ Valve
Navitor™ TAVI System: Minimizing PPI Risks
Read morePPI Rates of 10% or Lower Using Best Implant Practices
Structural Interventions
Amplatzer™ Atrial Septal Occluder
Read moreUnique Device for Closing PDAs Demonstrates High Levels of Safety and Effectiveness
Amplatzer™ Amulet™ LAA Occluder
Read moreEmerge LAA Post-Approval Study: Presentations and Publications Year-in-Review
Amplatzer™ Amulet™ LAA Occluder
Read moreLAAO Stroke Risk Reduction: Device-Related Factors Considerations
Amplatzer™ Amulet™ LAA Occluder
Read moreEmerge LAA Post-Approval Study: Outcomes for SAPT, DAPT, or OAC after Amplatzer™ Amulet™ LAA Occluder Implantation
Surgical Valve Solutions
Epic™ Mitral Stented Tissue Valve with Linx™ AC Technology
Read more
Epic Mitral – Ten Year Clinical Outcomes of SMVR in a Medicare Population1Epic™ Supra Aortic Stented Tissue Valve with Linx™ AC Technology
Read moreTen-Years Outcomes of a Contemporary Supra-Annular Porcine Aortic Bioprosthesis in a Medicare Population1
Epic™ Mitral and Epic™ Supra Stented Tissue Valves
Read more
Three-Year Outcomes of Valve-in-Valve Intervention within the Epic™ Supra and Epic™ Mitral Valves in a Medicare PopulationMasters Series Mitral Mechanical Heart Valves
Read moreKey Mitral MHV Selection Considerations: Durability, Size Range, Hemodynamics and Implantability1
Tissue Heart Valves
Read moreComparison of Failure Modes of Bioprosthetic Porcine Valves versus Bovine Pericardial Valves
Mechanical Heart Valves
Read moreBioprosthetic vs. Mechanical Aortic Valve Replacement in Patients 40–75 Years
CLINICAL DATA | TRANSCATHETER VALVE SOLUTIONS
CLINICAL DATA | SURGICAL VALVE SOLUTIONS
CLINICAL DATA | STRUCTURAL INTERVENTIONS
MAT-2004712 v22.0 | Item approved for OUS use only.